2nd Quarter - Report

PODESTA GROUP, INC. for BRISTOL-MYERS SQUIBB

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H. R. 3162, Children's Health and Medicare Protection Act of 2007 H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H. R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008

LobbyistCovered position, as disclosed
PAUL BRATHWAITE Exec. Dir., Congressional Black Caucus
SHARON COHEN —
ANNE MARIE POLAK Leg. Correspondent for Cong. Mike Ferguson
LANTIE SLENZAK Legislative Director, Rep. Gene Green

Contacted: Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 3 (110th), S. 3101 (110th), S. 2662 (110th), H.R. 6331 (110th), H.R. 4 (110th), S. 2029 (110th), H.R. 5480 (110th), S. 1376 (110th), H.R. 2606 (110th), H.R. 3162 (110th)

Pharmacy PHA

H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics Drug importation H.R. 5629, Pathway for Biosimilars Act H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008

LobbyistCovered position, as disclosed
PAUL BRATHWAITE Exec. Dir., Congressional Black Caucus
SHARON COHEN —
ANNE MARIE POLAK Leg. Correspondent for Cong. Mike Ferguson

Contacted: Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Bills named: S. 1505 (110th), S. 1695 (110th), S. 2029 (110th), S. 596 (110th), S. 623 (110th), H.R. 1561 (110th), H.R. 5839 (110th), H.R. 1038 (110th), H.R. 1956 (110th), H.R. 5629 (110th)

Medical/Disease Research/Clinical Labs MED

LHHS appropriations Diabetes research issues Comparative effectiveness

LobbyistCovered position, as disclosed
PAUL BRATHWAITE Exec. Dir., Congressional Black Caucus
SHARON COHEN —
ANNE MARIE POLAK Leg. Correspondent for Cong. Mike Ferguson

Contacted: Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

S. 1145, Patent Reform Act of 2007, entire bill H. R. 1908, Patent Reform Act of 2007, entire bill

LobbyistCovered position, as disclosed
DANIELE BAIERLEIN —
PAUL BRATHWAITE Exec. Dir., Congressional Black Caucus
SHARON COHEN —
COURTNEY HAGEN —
ANNE MARIE POLAK Leg. Correspondent for Cong. Mike Ferguson

Contacted: Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1908 (110th), S. 1145 (110th)

Budget/Appropriations BUD

FY09 Administration Budget House Concurrent Resolution 312 FY09 Revised Congressional Budget Senate Concurrent Resolution 70 FY09 Congressional Budget Comparative Effectiveness FDA/drug importation issues

LobbyistCovered position, as disclosed
SHARON COHEN —
ANNE MARIE POLAK Leg. Correspondent for Rep. Mike Ferguson

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.